666

GUOBANG PHARMA LTD.

No trades
See on Supercharts
Market capitalization
‪9.31 B‬CNY
‪612.46 M‬CNY
‪5.31 B‬CNY
‪300.72 M‬
Beta (1Y)
1.11

About GUOBANG PHARMA LTD.

Headquarters
Shaoxing
Employees (FY)
‪4.23 K‬
Website
Founded
1996
ISIN
CNE100004NS2
FIGI
BBG00V1JRNH0
Guobang Pharma Ltd. engages in the research, development, manufacturing and sale of medicine and animal health products. Its main products include active pharmaceutical ingredients, key pharmaceutical intermediates, preparations, and additives. The company was founded on March 29, 1996 and is headquartered in Shaoxing, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 605507 is 16.66 CNY — it has increased by 1.15% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GUOBANG PHARMA LTD. stocks are traded under the ticker 605507.
605507 stock is 2.81% volatile and has beta coefficient of 1.11. Check out the list of the most volatile stocks — is GUOBANG PHARMA LTD. there?
Yes, you can track GUOBANG PHARMA LTD. financials in yearly and quarterly reports right on TradingView.
605507 stock has risen by 3.74% compared to the previous week, the month change is a 11.44% rise, over the last year GUOBANG PHARMA LTD. has showed a 27.50% decrease.
605507 net income for the last quarter is ‪198.73 M‬ CNY, while the quarter before that showed ‪123.39 M‬ CNY of net income which accounts for 61.06% change. Track more GUOBANG PHARMA LTD. financial stats to get the full picture.
Today GUOBANG PHARMA LTD. has the market capitalization of ‪9.31 B‬, it has decreased by 3.05% over the last week.
Yes, 605507 dividends are paid annually. The last dividend per share was 0.60 CNY. As of today, Dividend Yield (TTM)% is 3.60%. Tracking GUOBANG PHARMA LTD. dividends might help you take more informed decisions.
GUOBANG PHARMA LTD. dividend yield was 1.71% in 2023, and payout ratio reached 27.37%. The year before the numbers were 2.27% and 36.41% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 605507 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUOBANG PHARMA LTD. stock right from TradingView charts — choose your broker and connect to your account.
605507 reached its all-time high on Aug 3, 2021 with the price of 47.90 CNY, and its all-time low was 13.01 CNY and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has ‪4.23 K‬ employees. See our rating of the largest employees — is GUOBANG PHARMA LTD. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUOBANG PHARMA LTD. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUOBANG PHARMA LTD. stock shows the sell signal. See more of GUOBANG PHARMA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.